Your browser doesn't support javascript.
loading
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
Mar, Nataliya; Zakharia, Yousef; Falcon, Alejandro; Morales-Barrera, Rafael; Mellado, Begona; Duran, Ignacio; Oh, Do-Youn; Williamson, Stephen K; Gajate, Pablo; Arkenau, Hendrik-Tobias; Jones, Robert J; Teo, Min Yuen; Turan, Tolga; McLaughlin, Robert T; Peltier, Hillary M; Chong, Elizabeth; Atluri, Harisha; Dean, James P; Castellano, Daniel.
Afiliação
  • Mar N; Division of Hematology/Oncology, University of California Irvine, Orange, CA 92868, USA.
  • Zakharia Y; Division of Hematology/Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.
  • Falcon A; Hospital Universitario Virgen del Rocío, 41013 Seville, Spain.
  • Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Mellado B; Medical Oncology Department, Hospital Clínic i Provincial de Barcelona, Institut D'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain.
  • Duran I; Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), 39011 Santander, Spain.
  • Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Graduate School, Seoul 03080, Republic of Korea.
  • Williamson SK; University of Kansas Hospital Cancer Center, Kansas City, KS 64114, USA.
  • Gajate P; Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
  • Arkenau HT; Sarah Cannon Research Institute United Kingdom (SCRI-UK) and University College London Cancer Institute, London W1G 6AD, UK.
  • Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow G12 0YN, UK.
  • Teo MY; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Turan T; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • McLaughlin RT; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Peltier HM; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Chong E; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Atluri H; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Dean JP; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA 94080, USA.
  • Castellano D; Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Cancers (Basel) ; 15(11)2023 May 30.
Article em En | MEDLINE | ID: mdl-37296940

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article